C. O'Keefe

2.4k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

C. O'Keefe is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, C. O'Keefe has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Genetics and 5 papers in Immunology. Recurrent topics in C. O'Keefe's work include Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Complement system in diseases (3 papers). C. O'Keefe is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Complement system in diseases (3 papers). C. O'Keefe collaborates with scholars based in United States, Japan and Canada. C. O'Keefe's co-authors include A. Gregory Matera, Yue Xiong, Xiaoyu Wu, Kun‐Liang Guan, Christopher W. Davies‐Jenkins, M.A. Nichols, Jaroslaw P. Maciejewski, Ramón V. Tiu, Yuka Sugimoto and Mikkael A. Sekeres and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Journal of Nutrition.

In The Last Decade

C. O'Keefe

18 papers receiving 1.4k citations

Hit Papers

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/M... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. O'Keefe United States 13 831 599 486 253 194 18 1.5k
Shinichi Mizuno Japan 16 1.0k 1.3× 405 0.7× 698 1.4× 210 0.8× 316 1.6× 46 1.8k
Thierry Lavabre‐Bertrand France 19 597 0.7× 377 0.6× 318 0.7× 237 0.9× 309 1.6× 59 1.4k
Ya‐Wei Qiang United States 16 1.1k 1.3× 685 1.1× 620 1.3× 109 0.4× 103 0.5× 35 1.6k
Shin‐ichiro Takayanagi Japan 14 634 0.8× 553 0.9× 617 1.3× 177 0.7× 635 3.3× 29 1.6k
Kumiko Goi Japan 21 665 0.8× 356 0.6× 341 0.7× 148 0.6× 191 1.0× 78 1.2k
Frederick Racke United States 20 747 0.9× 220 0.4× 708 1.5× 310 1.2× 388 2.0× 44 1.7k
Teresa Flores Spain 19 539 0.6× 492 0.8× 255 0.5× 285 1.1× 191 1.0× 25 1.3k
Manabu Inuzuka Japan 13 1.1k 1.4× 341 0.6× 545 1.1× 84 0.3× 224 1.2× 24 1.5k
Akihide Yoshimi Japan 23 994 1.2× 231 0.4× 683 1.4× 250 1.0× 229 1.2× 64 1.6k
Robert Coupland Canada 22 429 0.5× 683 1.1× 329 0.7× 477 1.9× 241 1.2× 40 1.7k

Countries citing papers authored by C. O'Keefe

Since Specialization
Citations

This map shows the geographic impact of C. O'Keefe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. O'Keefe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. O'Keefe more than expected).

Fields of papers citing papers by C. O'Keefe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. O'Keefe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. O'Keefe. The network helps show where C. O'Keefe may publish in the future.

Co-authorship network of co-authors of C. O'Keefe

This figure shows the co-authorship network connecting the top 25 collaborators of C. O'Keefe. A scholar is included among the top collaborators of C. O'Keefe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. O'Keefe. C. O'Keefe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Khan, Shahper N., A. Jankowska, Reda Z. Mahfouz, et al.. (2013). Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia. 27(6). 1301–1309. 104 indexed citations
2.
Traina, Fabı́ola, Valeria Visconte, Paul Elson, et al.. (2013). Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia. 28(1). 78–87. 219 indexed citations
3.
Makishima, Hideki, Yuka Sugimoto, Hadrian Szpurka, et al.. (2012). CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. Leukemia. 26(7). 1547–1554. 14 indexed citations
4.
Sugimori, Chiharu, Eric Padron, Gisela Cáceres, et al.. (2012). Paroxysmal nocturnal hemoglobinuria and concurrent JAK2V617F mutation. Blood Cancer Journal. 2(3). e63–e63. 25 indexed citations
6.
Afable, Manuel, Mohammed A. Shaik, Yuka Sugimoto, et al.. (2011). Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia. Haematologica. 96(9). 1269–1275. 75 indexed citations
7.
Bhatnagar, Bhavana, Ramón V. Tiu, Lukasz P. Gondek, et al.. (2009). Use of SNP-array-based karyotyping for cytogenetic prognostication in unclassified cases of myelodysplasia and associated overlap disorders. Journal of Clinical Oncology. 27(15_suppl). 7016–7016. 1 indexed citations
8.
Tiu, Ramón V., Lukasz P. Gondek, Jin Hoe Huh, et al.. (2009). P035 Improvement in cytogenetic diagnosis and clinical prognostication using SNP-A karyotyping in combination with metaphase cytogenetics in MDS, MDS/MPD and secondary AML. Leukemia Research. 33. S78–S79. 1 indexed citations
9.
Serio, Bianca, Andrew Dunbar, C. O'Keefe, et al.. (2008). Double‐negative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 141(2). 170–178. 47 indexed citations
10.
Tiu, Ramón V., Lukasz P. Gondek, C. O'Keefe, & Jaroslaw P. Maciejewski. (2007). Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes. Leukemia. 21(8). 1648–1657. 42 indexed citations
11.
Risitano, Antonio M., Jaroslaw P. Maciejewski, Pawel Muranski, et al.. (2005). Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients. Leukemia. 19(2). 217–222. 47 indexed citations
12.
Włodarski, Marcin W., et al.. (2005). O-61 Molecular analysis of CTL responses in myelodysplastic syndrome and other bone marrow failure states. Leukemia Research. 29. S21–S22. 1 indexed citations
13.
O'Keefe, C., et al.. (1997). Alphoid variant-specific FISH probes can distinguish autosomal meiosis I from meiosis II non-disjunction in human sperm. Human Genetics. 101(1). 61–66. 10 indexed citations
14.
Guan, Kun‐Liang, Christopher W. Davies‐Jenkins, Y Li, et al.. (1996). Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.. Molecular Biology of the Cell. 7(1). 57–70. 99 indexed citations
15.
O'Keefe, C.. (1996). Oligonucleotide probes for alpha satellite DNA variants can distinguish homologous chromosomes by FISH. Human Molecular Genetics. 5(11). 1793–1799. 26 indexed citations
16.
O'Keefe, C., Lynn B. Bailey, Elizabeth A. Thomas, et al.. (1995). Controlled Dietary Folate Affects Folate Status in Nonpregnant Women. Journal of Nutrition. 125(10). 2717–2725. 79 indexed citations
17.
Margolese, Howard C., et al.. (1994). Expression of Major Histocompatibility Complex Class II Antigen in Nod Mouse Thyroid. Autoimmunity. 17(1). 1–11. 7 indexed citations
18.
Guan, Kun‐Liang, Christopher W. Davies‐Jenkins, M.A. Nichols, et al.. (1994). Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.. Genes & Development. 8(24). 2939–2952. 610 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026